TMCnet News
Corticon Provides CSC with Power CareVeillance Real-Time Clinical Surveillance SoftwareFeb 25, 2011 (Close-Up Media via COMTEX) -- CSC, a global consulting, systems integration and outsourcing company, announced that it has selected Corticon Technologies, a provider of Business Rules Management Systems (BRMS) as a business rules platform partner for its CareVeillance real-time clinical surveillance software. CSC will leverage Corticon's BRMS to implement the solution, and, going forward, will collaborate with Corticon to develop new solutions to automate best practices within the healthcare industry. As the healthcare industry faces change and reform, new government-mandated quality standards have been introduced and healthcare providers are being held to these standards, with reduced reimbursement for those who fail to meet them. According to the government mandate, hospitals must show that they provided the appropriate care, and avoided patient complications, before they are reimbursed for treatment. In addition, this quality information must also be collected and validated by hospitals as the patient is treated, not after the fact. CareVeillance, CSC's first Corticon-powered solution, is a software tool that provides real-time clinical surveillance and reporting for hospitals by continuously monitoring and evaluating clinical information generated during patient care. CSC's CareVeillance Clinical Surveillance incorporates Corticon's BRMS to identify and alert clinicians to patients showing early signs of high risk conditions such as sepsis or pneumonia. This allows caregivers the earliest possible opportunity to assess and treat at-risk patients, and to ensure that best practice measures are delivered during critical time frames. "Business rules platforms are an advanced technology with the potential to transform healthcare services delivery," says Mark Roman, president of CSC Global Healthcare Services. "With Corticon's Business Rules Management System, we can empower healthcare companies to detect high risk conditions earlier than previously possible and automate industry best practice, which can both reduce costs and improve quality of care." "We are eager to partner with CSC to deliver the next generation of clinical intelligence solutions," said Mark Allen, M.D., CEO and co-founder of Corticon. "Corticon has proven that rule-based, clinical decision support systems can improve the quality of care, while reducing costs, by suggesting only the appropriate tests and treatments to healthcare professionals. In the past, hospitals were paid for all charges, whether indicated or not. This provided a negative financial incentive to leverage and experience the full benefits of these clinical information systems." CSC's Healthcare Group, which serves healthcare providers, health plans, pharmaceutical and medical device manufacturers, and allied industries around the world, is a global provider of solutions that transform the healthcare industry through the use of information to improve healthcare outcomes, decision-making and operating efficiency. ((Comments on this story may be sent to [email protected])) |